CUE vs QCOM · rev $9.3M vs P/E 16, rev $44.28B
Cue Biopharma (CUE) versus Qualcomm Incorporated (QCOM) — a side-by-side from cached financials, not a winner call.
Cue Biopharma (CUE) is a biotechnology company listed on US.
Qualcomm Incorporated (QCOM) is a semiconductors company listed on US. It is led by Cristiano Amon.
Latest reported CUE revenue for 2024-12-31 was $9.3M. Net income was -$40.7M. Revenue was up 69.2% from 2023-12-31 to 2024-12-31. CUE currently screens at market cap $59.5M.
Latest reported QCOM revenue for 2025-09-28 was $44.28B. Net income was $5.54B. QCOM currently screens at market cap $175.02B and trailing P/E 16.3.
CUE currently screens at market cap $59.5M. QCOM currently screens at market cap $175.02B and trailing P/E 16.3.
Not investment advice. Open the CUE and QCOM stock pages for the full models.
Not investment advice.